ロード中...

Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial

IMPORTANCE: The 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol identified patients with recent (past 12 months) myocardial infarction (MI) as very high risk, in whom a PCSK9 inhibitor is reasonable to add to maximally tole...

詳細記述

保存先:
書誌詳細
出版年:JAMA Cardiol
主要な著者: Gencer, Baris, Mach, François, Murphy, Sabina A., De Ferrari, Gaetano M., Huber, Kurt, Lewis, Basil S., Ferreira, Jorge, Kurtz, Christopher E., Wang, Huei, Honarpour, Narimon, Keech, Anthony C., Sever, Peter S., Pedersen, Terje R., Sabatine, Marc S., Giugliano, Robert P.
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7240652/
https://ncbi.nlm.nih.gov/pubmed/32432684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.0882
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!